| Chair: | ||||
|---|---|---|---|---|
| 08:30 | 3D mapping in the treatment of supraventricular tachycardia | Dr Sajad Hayat | Doha, QA | |
| 08:50 | Visualisation of the human conduction system with 3D mapping | Dr Balrik Kailey | London, UK | |
| 09:10 | Affera | |||
| 09:30 | Catheter ablation as a treatment for vaso-vagal syncope | |||
| 09:50 | Q and A | |||
| 10:00 | Close |
| Chair: | ||||
|---|---|---|---|---|
| 08:30 | What is syncope? How does it change with age? | |||
| 08:50 | Tilt testing: new methodological aspects | |||
| 09:10 | Ambulatory Blood Pressure Monitors and syncope diagnosis | Dr Artur Fedorowski | Stockholm, SE | |
| 09:30 | Tilt tests and Implantable Recorders | |||
| 09:50 | Discussion | |||
| 10:00 | Close |
| Chair: Dr Vinay Bhole | Birmingham, UK | |||
|---|---|---|---|---|
| 08:30 | Anatomy and physiology of cardiac conduction system | Dr Vinay Bhole | Birmingham, UK | |
| 08:50 | Foundations of correct EP study and conduction interval measurements | |||
| 09:10 | Fundamentals of EPS stimulation for SVT and VT induction | Dr Vinay Bhole | Birmingham, UK | |
| 09:30 | EP manoeuvres to differentiate SVT and VT types; basics of entrainment | |||
| 09:50 | Questions | |||
| 10:00 | Close |
| Panel | Mr Paul Doherty | Solihull, UK | ||
| 10:00 | Close |
| Chair: Dr Fu Siong Ng | London, UK | |||
|---|---|---|---|---|
| 10:45 | Action potential (and T wave) alternans and arrhythmias | |||
| 11:05 | Should I use digoxin in my patient with AF? | |||
| 11:25 | Do my genes determine whether I will have arrhythmias? | |||
| 11:45 | Making models of atrial fibrillation | Dr Caroline Roney | London, UK | |
| 12:05 | Q and A | |||
| 12:15 | Close |
| Chair: Prof Carlos Morillo, Dr Nicholas Gall | Calgary, CA; Madrid, SP, London, UK | |||
|---|---|---|---|---|
| 10:45 | Does vasovagal syncope portend a fatal risk? | |||
| 11:05 | Organisation of syncope care in the Netherlands. Can it be applied internationally? | Dr I.A. van Rossum | Leiden, NL | |
| 11:25 | Syncope in ED and in clinics: are they the same patients? | |||
| 11:45 | Syncope in ED in Canada and US | Dr Roopinder Sandhu | Los Angeles, US | |
| 12:05 | Discussion | |||
| 12:15 | Close |
| Chair: | ||||
|---|---|---|---|---|
| 10:45 | Risk calculation criteria in HCM, ARVC, LVNC and DCM | Prof Juan Pablo Kaski | London, UK | |
| 11:05 | Risk stratification in LQT with different formulas and tests | |||
| 11:25 | Is it necessary to risk stratify children with Brugada and how? | |||
| 11:45 | CPVT and risk stratification principles, why and how? | |||
| 12:05 | Questions | |||
| 12:15 | Close |
| Chair: Dr Wajid Hussain | London, UK | |||
|---|---|---|---|---|
| 10:45 | AF Virtual Wards - Hope, hype or revolution? | |||
| 11:05 | Can Digital twins and aviators help clinical decision making? | Prof Sanjiv Narayan | Stanford, US | |
| 11:25 | Can Artificial intelligence improve outcomes for AF ablation? | Prof Natasja de Groot | Rotterdam, NL | |
| 11:45 | Does Chat GPT have the potential enhance arrhythmia patient care? | |||
| 12:05 | Discussion | |||
| 12:15 | Close |
| Chair: Dr Keenan Saleh | London, UK | |||
|---|---|---|---|---|
| 13:30 | An introduction to device extraction for early trainees | |||
| 13:50 | A structured approach to mapping accessory pathways | Dr Nick Linton | London, UK | |
| 14:10 | AF ablation: a practical guide and workflow | Dr Bradley Porter | London, UK | |
| 14:30 | Device troubleshooting: approach and cases | |||
| 14:50 | Q and A | |||
| 15:00 | Close |
| Chair: | ||||
|---|---|---|---|---|
| 13:30 | Ablate and Pace-Who, when and what device? | Prof Aldo Rinaldi | London, UK | |
| 13:55 | AF ablation in HFrEF-Do we have the answer? | |||
| 14:20 | AF ablation in HfpEF | |||
| 14:45 | Discussion | |||
| 15:00 | Close |
| Chair: | ||||
|---|---|---|---|---|
| 13:30 | PoTS: purely haemodynamics or a multisystem disease? | Dr Artur Fedorowski | Stockholm, SE | |
| 13:50 | PoTS: negative impact on just about everything | |||
| 14:10 | PoTS: current non-medical treatments | Prof Satish Raj | Calgary, CA | |
| 14:30 | PoTS: do drugs have sustained benefit? | Dr Nicholas Gall | London, UK | |
| 14:50 | Discussion | |||
| 15:00 | Close |
| Chair: | ||||
|---|---|---|---|---|
| 13:30 | Device implant tips and tricks, is it time for non-physician implantation? | |||
| 13:45 | Optimising the SICD, exploiting SMARTPASS filter | Mr Christopher Monkhouse | London, UK | |
| 14:00 | Cognitive behavioural therapy for VT patients | |||
| 14:15 | Getting the best out of your CRT patients | Miss Charlotte Mehegan | Suffolk, UK | |
| 14:30 | Rate response in CRT patients, what is the evidence? | |||
| 14:45 | Blister Infection score- Cost effective use to TYRX envelope | |||
| 15:00 | Close |
| Chair: | ||||
|---|---|---|---|---|
| 13:30 | How is clinical types of AVNRT diagnosed on 12 lead ECG and in the EP lab? | |||
| 13:50 | How to differentiate different types of accessory pathways during EPS? | |||
| 14:10 | Primers of transoesophageal and subcutaneous pacing | |||
| 14:30 | Pacing principles in the intensive care unit following congenital cardiac surgery | Dr Michael Bowes | Liverpool, UK | |
| 14:50 | Questions | |||
| 15:00 | Close |
| Chair: Dr Fu Siong Ng | London, UK |
|---|
| Chair: Prof Elijah Behr | London, UK | |||
|---|---|---|---|---|
| 13:30 | Introduction/Setting the scene/Treatment OOHCA | |||
| 14:00 | Ventricular Tachycardia | |||
| 14:30 | Genetics | Dr Stephen Page | Leeds, UK | |
| 15:00 | Close |
| Chair: Dr Angela Hall | Jersey, UK | |||
|---|---|---|---|---|
| 15:45 | AF Virtual Ward | Mrs Sue Armstrong | Leicester, UK | |
| 16:05 | Pre-op EP service - our data | |||
| 16:25 | Arrhythmia Nurse Competencies | Ms Ting Fang Feng | Watford, UK | |
| 16:45 | How can we facilitate research in a busy arrhythmia team? | |||
| 17:05 | Q and A | |||
| 17:15 | Close |
| Chair: | ||||
|---|---|---|---|---|
| 15:45 | Update on role of cardioinhibition | Dr I.A. van Rossum | Leiden, NL | |
| 16:05 | Sleep Syncope | |||
| 16:25 | Developments in oral therapy for VVS | |||
| 16:45 | Cardioneuroablation | Prof Carlos Morillo | Calgary, CA; Madrid, SP | |
| 17:05 | Discussion | |||
| 17:15 | Close |
| Chair: | ||||
|---|---|---|---|---|
| 15:45 | How to manage acute SVT in infants and older children with cardiac failure? | |||
| 16:05 | How to interpret Holter in arrhythmia scenarios, back to basics | Dr Gulhan Tunca | Istanbul, TR | |
| 16:25 | Potpourri of my nightmare arrhythmia cases: how did I survive? | |||
| 16:45 | Antiarrhythmic choices for maintenance therapy of SVT and why? | |||
| 17:05 | Questions | |||
| Chair: | ||||
| 17:15 | Paediatric Abstract Discussion 1 - TBC | |||
| 17:20 | Paediatric Abstract Discussion 2 - TBC | |||
| 17:25 | Paediatric Abstract Discussion 3 - TBC | |||
| 17:30 | Close |
| Chair: Dr Fu Siong Ng | London, UK |
|---|
| Chair: | ||||
|---|---|---|---|---|
| 15:45 | CIED infections: Just What are the Risks? | |||
| 16:15 | Prevention / Treatment Options (non-extraction) | |||
| 16:45 | Extraction | |||
| 17:15 | Close |